197 related articles for article (PubMed ID: 30053488)
21. Amorphous powders for inhalation drug delivery.
Chen L; Okuda T; Lu XY; Chan HK
Adv Drug Deliv Rev; 2016 May; 100():102-15. PubMed ID: 26780404
[TBL] [Abstract][Full Text] [Related]
22. Formulation Design of Dry Powders for Inhalation.
Weers JG; Miller DP
J Pharm Sci; 2015 Oct; 104(10):3259-88. PubMed ID: 26296055
[TBL] [Abstract][Full Text] [Related]
23. Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs.
Miller DP; Tan T; Tarara TE; Nakamura J; Malcolmson RJ; Weers JG
Mol Pharm; 2015 Aug; 12(8):2582-93. PubMed ID: 26052676
[TBL] [Abstract][Full Text] [Related]
24. Electrohydrodynamic methods for the development of pulmonary drug delivery systems.
Nikolaou M; Krasia-Christoforou T
Eur J Pharm Sci; 2018 Feb; 113():29-40. PubMed ID: 28865687
[TBL] [Abstract][Full Text] [Related]
25. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
[TBL] [Abstract][Full Text] [Related]
26. Dosing challenges in respiratory therapies.
Yeung S; Traini D; Lewis D; Young PM
Int J Pharm; 2018 Sep; 548(1):659-671. PubMed ID: 30033395
[TBL] [Abstract][Full Text] [Related]
27. Formulation considerations for dry powder inhalers.
Cordts E; Steckel H
Ther Deliv; 2014 Jun; 5(6):675-89. PubMed ID: 25090281
[TBL] [Abstract][Full Text] [Related]
28. [A novel pulmonary delivery system--dry powder inhalers].
Tang Y; Zhu JB; Chen XJ
Yao Xue Xue Bao; 2009 Jun; 44(6):571-4. PubMed ID: 19806884
[TBL] [Abstract][Full Text] [Related]
29. The role of disposable inhalers in pulmonary drug delivery.
de Boer AH; Hagedoorn P
Expert Opin Drug Deliv; 2015 Jan; 12(1):143-57. PubMed ID: 25374325
[TBL] [Abstract][Full Text] [Related]
30. Alternative carriers in dry powder inhaler formulations.
Rahimpour Y; Kouhsoltani M; Hamishehkar H
Drug Discov Today; 2014 May; 19(5):618-26. PubMed ID: 24269834
[TBL] [Abstract][Full Text] [Related]
31. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
[TBL] [Abstract][Full Text] [Related]
32. Single-use disposable dry powder inhalers for pulmonary drug delivery.
Friebel C; Steckel H
Expert Opin Drug Deliv; 2010 Dec; 7(12):1359-72. PubMed ID: 21080859
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary drug delivery by powder aerosols.
Yang MY; Chan JG; Chan HK
J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
[TBL] [Abstract][Full Text] [Related]
34. The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic Inhaler.
Parumasivam T; Leung SS; Tang P; Mauro C; Britton W; Chan HK
AAPS J; 2017 Jan; 19(1):191-202. PubMed ID: 27679516
[TBL] [Abstract][Full Text] [Related]
35. How can we bring high drug doses to the lung?
Claus S; Weiler C; Schiewe J; Friess W
Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
[TBL] [Abstract][Full Text] [Related]
36. Technological and practical challenges of dry powder inhalers and formulations.
Hoppentocht M; Hagedoorn P; Frijlink HW; de Boer AH
Adv Drug Deliv Rev; 2014 Aug; 75():18-31. PubMed ID: 24735675
[TBL] [Abstract][Full Text] [Related]
37. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.
Grant AC; Walker R; Hamilton M; Garrill K
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):474-85. PubMed ID: 26372466
[TBL] [Abstract][Full Text] [Related]
38. Delivery of biotherapeutics by inhalation aerosol.
Niven RW
Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):151-231. PubMed ID: 9501969
[TBL] [Abstract][Full Text] [Related]
39. Drug Permeation Characterization of Inhaled Dry Powder Formulations in Air-Liquid Interfaced Cell Layer Using an Improved, Simple Apparatus for Dispersion.
Asai A; Okuda T; Sonoda E; Yamauchi T; Kato S; Okamoto H
Pharm Res; 2016 Feb; 33(2):487-97. PubMed ID: 26490362
[TBL] [Abstract][Full Text] [Related]
40. [Formulation of new generation drug delivery system for dry powder inhalation.].
Chvatal A; Szabo B; Szabo-Revesz P; Ambrus R
Acta Pharm Hung; 2016; 86(3):75-83. PubMed ID: 29489079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
